Vonvendi is a recombinant von Willebrand factor, FDA approved for use in adults with von Willebrand disease (vWD) for on-demand treatment and control of bleeding episodes. Contains large and ultra-large von Willebrand factor (vWF) multimers but lacks factor VIII (FVIII) so that patients may have to be supplemented with FVIII product.
